Haifeng Sun

Haifeng Sun

Auto-generated profile, based on publicly available information

Haifeng Sun

Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Biomaterials
Verified
Journal Article
Open access
YZYulin Zhang
Yulin Zhang
KXKaiyan Xi
Kaiyan Xi
XFXiao Fu
Xiao Fu
HSHaifeng Sun
Haifeng Sun
HWHong Wang
Hong Wang
SNShilei Ni
Shilei Ni
Glioblastoma multiforme (GBM) is a common malignancy of the central nervous system, but conventional treatments yield unsatisfactory results. Although innovative therapeutic approaches have been developed, they prolong survival by only approximately 5 months. The heterogeneity of GBM renders growth inhibition with a single drug difficult, and exploring combination approaches with multiple targets for the comprehensive treatment of GBM is expected to overcome this limitation. In this study, we designed a biocompatible cRGD/Pt + DOX@GFNPs (RPDGs) nanoformulation to disrupt redox homeostasis in GBM cells and promote the simultaneous occurrence of efficient apoptosis and ferroptosis. Taking advantage of the highly stable Fenton reaction catalytic activity of gallic acid (GA)/Fe2+ nanoparticles in physiological environments, the ability of Pt (IV) to deplete glutathione (GSH) and increase reactive oxygen species (ROS) levels, and the efficient photothermal conversion efficiency of GA/Fe2+ nanoparticles, our synthesized multifunctional and multitargeted RPDGs significantly increased intracellular ROS levels and thus induced ferroptosis. Furthermore, the RPDGs displayed superior photothermal responsiveness and magnetic resonance imaging (MRI) capabilities. These results indicate that RPDGs can not only directly inhibit the growth of tumors but also effectively improve the efficient translocation of conventional chemotherapeutic drugs across the blood-brain barrier, thereby providing a new approach for the comprehensive treatment of GBM.

7 August 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
QYQun Yu
Qun Yu
YTYuan Tian
Yuan Tian
MLMeng Li
Meng Li
YJYuan Jiang
Yuan Jiang
HSHaifeng Sun
Haifeng Sun
JCJiwei Cui
Jiwei Cui
Scalable mineralization of zeolitic imidazolate framework-8 nanoparticles with versatility of cargo encapsulation and excellent colloidal dispersibility and stability is engineered using poly(ethylene glycol) as the mineralizer for therapeutic delivery.

22 March 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
GZGuiqiang Zhang
Guiqiang Zhang
XFXiao Fu
Xiao Fu
HSHaifeng Sun
Haifeng Sun
PZPeiyu Zhang
Peiyu Zhang
SZShumei Zhai
Shumei Zhai
MHMing Hu
Ming Hu

4 March 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
LJLina Jiao
Lina Jiao
HJHaiyan Jin
Haiyan Jin
ZSZuchen Song
Zuchen Song
ZWZheng Wang
Zheng Wang
LYLin Yu
Lin Yu
ZLZhenguang Liu
Zhenguang Liu

25 March 2021 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
HSHaifeng Sun
Haifeng Sun
ZZZhonghe Zhang
Zhonghe Zhang
XKXiaoyu Kang
Xiaoyu Kang
QDQiong Dai
Qiong Dai
ASAixin Song
Aixin Song
JCJiwei Cui
Jiwei Cui
The use of biologically-derived nanoparticles from mung beans for combination chemo-ferroptosis therapy and magnetic resonance imaging is reported, which highlights the potential of the nanoparticles for biomedical applications.